Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.99 - $2.4 $5.24 Million - $12.7 Million
-5,296,501 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$2.3 - $4.3 $110,634 - $206,838
48,102 Added 0.92%
5,296,501 $1.51 Million
Q4 2021

Feb 14, 2022

BUY
$2.7 - $4.5 $8.73 Million - $14.6 Million
3,233,601 Added 160.49%
5,248,399 $1.43 Million
Q2 2021

Aug 13, 2021

BUY
$4.6 - $7.2 $9.27 Million - $14.5 Million
2,014,798 New
2,014,798 $1.21 Million

About Synthetic Biologics, Inc.


  • Ticker SYN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,844,100
  • Market Cap $9.51M
  • Description
  • Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...
More about SYN
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.